UGT1A1 and Thrombocytopenia: In summary, the polymorphism of UGT1A1*28 gene was associated with the incidence of severe thrombocytopenia in cancer patients during IRI chemotherapy, and the incidence of mutation (TA6/7 + TA7/7) was higher in severe thrombocytopenia.